US20190321312A1 – October 24, 2019 – Compositions to Treat Anal Itch

Please complete the required fields.




Inventors :

Robert A. Ganz; Mo E. Saremi; William Christopfel

Owner :

G&S LABORATORIES, INC.

Application Number :

US16388649

Document Number :

US20190321312A1

Priority Date :

April 18, 2019

Filing Date :

April 18, 2019

Date of Grant/ Publication :

October 24, 2019

Class :

A61K31 / 167; A61K31 / 4406; A61K47 / 02; A61K47 / 44; A61K47 / 46; A61K9 / 00; A61P17 / 04

Abstract

The present disclosure relates to topical compositions comprising one or more topical anesthetics or analgesics; a vitamin B3 compound; and a coating agent. In some embodiments, the composition comprises about 1% to about 10% w/w of the composition of the topical anesthetic, topical analgesic, or a combination thereof; about 1% to about 10% w/w of the composition of the vitamin B3 compound; and about 5% to about 50% w/w of the composition of the coating agent. In some embodiments, the composition further includes a pharmaceutically acceptable base. In some embodiments, the pharmaceutically acceptable base comprises about 35% to about 85% w/w of the composition of a pharmaceutically acceptable oil; about 1% to about 20% w/w of the composition of a pharmaceutically acceptable wax; or a combination thereof. Such compositions are useful for treating anal itch or pruritus ani.

Claim(s)

1 . A composition comprising: a topical anesthetic, a topical analgesic, or a combination thereof; a coating agent; and a vitamin B3 compound.;
14 .- 16 . (canceled);
23 . (canceled);
26 .- 29 . (canceled);
33 . (canceled);
35 .- 41 . (canceled);
42 . A composition comprising: sunflower seed oil; olive oil; lidocaine; zinc oxide; niacinamide; and beeswax.;
43 . (canceled);
44 . (canceled);
46 .- 51 . (canceled);
53 . (canceled);
55 .- 57 . (canceled)

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login